Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages.

Market Analysis and Insights: Global Acquired Hemophilia Treatment Market

The global Acquired Hemophilia Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Acquired Hemophilia Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Acquired Hemophilia Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Acquired Hemophilia Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acquired Hemophilia Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Acquired Hemophilia Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Acquired Hemophilia Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Acquired Hemophilia Treatment Market Report

Report Metric	Details
Report Name	Acquired Hemophilia Treatment Market
CAGR	5%
Segment by Type	Traditional Therapy Advanced Therapy
Segment by Application	Hospitals Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Baxalta, Inc., Baxter Healthcare Corporation, Bristol-Myers Squibb, Genentech, Inc., Novo Nordisk A/S, Ferring B.V., Sanofi SA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Acquired Hemophilia Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acquired Hemophilia Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acquired Hemophilia Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Acquired Hemophilia Treatment Market report?

Ans: The main players in the Acquired Hemophilia Treatment Market are Baxalta, Inc., Baxter Healthcare Corporation, Bristol-Myers Squibb, Genentech, Inc., Novo Nordisk A/S, Ferring B.V., Sanofi SA

What are the Application segmentation covered in the Acquired Hemophilia Treatment Market report?

Ans: The Applications covered in the Acquired Hemophilia Treatment Market report are Hospitals, Clinic, Others

What are the Type segmentation covered in the Acquired Hemophilia Treatment Market report?

Ans: The Types covered in the Acquired Hemophilia Treatment Market report are Traditional Therapy, Advanced Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Acquired Hemophilia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Traditional Therapy

1.2.3 Advanced Therapy

1.3 Market by Application

1.3.1 Global Acquired Hemophilia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Acquired Hemophilia Treatment Market Perspective (2019-2030)

2.2 Global Acquired Hemophilia Treatment Growth Trends by Region

2.2.1 Acquired Hemophilia Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Acquired Hemophilia Treatment Historic Market Size by Region (2019-2024)

2.2.3 Acquired Hemophilia Treatment Forecasted Market Size by Region (2025-2030)

2.3 Acquired Hemophilia Treatment Market Dynamics

2.3.1 Acquired Hemophilia Treatment Industry Trends

2.3.2 Acquired Hemophilia Treatment Market Drivers

2.3.3 Acquired Hemophilia Treatment Market Challenges

2.3.4 Acquired Hemophilia Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Acquired Hemophilia Treatment by Players

3.1.1 Global Acquired Hemophilia Treatment Revenue by Players (2019-2024)

3.1.2 Global Acquired Hemophilia Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Acquired Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Acquired Hemophilia Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Acquired Hemophilia Treatment Market Concentration Ratio

3.4.1 Global Acquired Hemophilia Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Acquired Hemophilia Treatment Revenue in 2023

3.5 Global Key Players of Acquired Hemophilia Treatment Head office and Area Served

3.6 Global Key Players of Acquired Hemophilia Treatment, Product and Application

3.7 Global Key Players of Acquired Hemophilia Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Acquired Hemophilia Treatment Breakdown Data by Type

4.1 Global Acquired Hemophilia Treatment Historic Market Size by Type (2019-2024)

4.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2025-2030)

5 Acquired Hemophilia Treatment Breakdown Data by Application

5.1 Global Acquired Hemophilia Treatment Historic Market Size by Application (2019-2024)

5.2 Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Acquired Hemophilia Treatment Market Size (2019-2030)

6.2 North America Acquired Hemophilia Treatment Market Size by Type

6.2.1 North America Acquired Hemophilia Treatment Market Size by Type (2019-2024)

6.2.2 North America Acquired Hemophilia Treatment Market Size by Type (2025-2030)

6.2.3 North America Acquired Hemophilia Treatment Market Share by Type (2019-2030)

6.3 North America Acquired Hemophilia Treatment Market Size by Application

6.3.1 North America Acquired Hemophilia Treatment Market Size by Application (2019-2024)

6.3.2 North America Acquired Hemophilia Treatment Market Size by Application (2025-2030)

6.3.3 North America Acquired Hemophilia Treatment Market Share by Application (2019-2030)

6.4 North America Acquired Hemophilia Treatment Market Size by Country

6.4.1 North America Acquired Hemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Acquired Hemophilia Treatment Market Size by Country (2019-2024)

6.4.3 North America Acquired Hemophilia Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Acquired Hemophilia Treatment Market Size (2019-2030)

7.2 Europe Acquired Hemophilia Treatment Market Size by Type

7.2.1 Europe Acquired Hemophilia Treatment Market Size by Type (2019-2024)

7.2.2 Europe Acquired Hemophilia Treatment Market Size by Type (2025-2030)

7.2.3 Europe Acquired Hemophilia Treatment Market Share by Type (2019-2030)

7.3 Europe Acquired Hemophilia Treatment Market Size by Application

7.3.1 Europe Acquired Hemophilia Treatment Market Size by Application (2019-2024)

7.3.2 Europe Acquired Hemophilia Treatment Market Size by Application (2025-2030)

7.3.3 Europe Acquired Hemophilia Treatment Market Share by Application (2019-2030)

7.4 Europe Acquired Hemophilia Treatment Market Size by Country

7.4.1 Europe Acquired Hemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Acquired Hemophilia Treatment Market Size by Country (2019-2024)

7.4.3 Europe Acquired Hemophilia Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Acquired Hemophilia Treatment Market Size (2019-2030)

8.2 China Acquired Hemophilia Treatment Market Size by Type

8.2.1 China Acquired Hemophilia Treatment Market Size by Type (2019-2024)

8.2.2 China Acquired Hemophilia Treatment Market Size by Type (2025-2030)

8.2.3 China Acquired Hemophilia Treatment Market Share by Type (2019-2030)

8.3 China Acquired Hemophilia Treatment Market Size by Application

8.3.1 China Acquired Hemophilia Treatment Market Size by Application (2019-2024)

8.3.2 China Acquired Hemophilia Treatment Market Size by Application (2025-2030)

8.3.3 China Acquired Hemophilia Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Acquired Hemophilia Treatment Market Size (2019-2030)

9.2 Asia Acquired Hemophilia Treatment Market Size by Type

9.2.1 Asia Acquired Hemophilia Treatment Market Size by Type (2019-2024)

9.2.2 Asia Acquired Hemophilia Treatment Market Size by Type (2025-2030)

9.2.3 Asia Acquired Hemophilia Treatment Market Share by Type (2019-2030)

9.3 Asia Acquired Hemophilia Treatment Market Size by Application

9.3.1 Asia Acquired Hemophilia Treatment Market Size by Application (2019-2024)

9.3.2 Asia Acquired Hemophilia Treatment Market Size by Application (2025-2030)

9.3.3 Asia Acquired Hemophilia Treatment Market Share by Application (2019-2030)

9.4 Asia Acquired Hemophilia Treatment Market Size by Region

9.4.1 Asia Acquired Hemophilia Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Acquired Hemophilia Treatment Market Size by Region (2019-2024)

9.4.3 Asia Acquired Hemophilia Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Baxalta, Inc.

11.1.1 Baxalta, Inc. Company Details

11.1.2 Baxalta, Inc. Business Overview

11.1.3 Baxalta, Inc. Acquired Hemophilia Treatment Introduction

11.1.4 Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.1.5 Baxalta, Inc. Recent Developments

11.2 Baxter Healthcare Corporation

11.2.1 Baxter Healthcare Corporation Company Details

11.2.2 Baxter Healthcare Corporation Business Overview

11.2.3 Baxter Healthcare Corporation Acquired Hemophilia Treatment Introduction

11.2.4 Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.2.5 Baxter Healthcare Corporation Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Acquired Hemophilia Treatment Introduction

11.3.4 Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 Genentech, Inc.

11.4.1 Genentech, Inc. Company Details

11.4.2 Genentech, Inc. Business Overview

11.4.3 Genentech, Inc. Acquired Hemophilia Treatment Introduction

11.4.4 Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.4.5 Genentech, Inc. Recent Developments

11.5 Novo Nordisk A/S

11.5.1 Novo Nordisk A/S Company Details

11.5.2 Novo Nordisk A/S Business Overview

11.5.3 Novo Nordisk A/S Acquired Hemophilia Treatment Introduction

11.5.4 Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.5.5 Novo Nordisk A/S Recent Developments

11.6 Ferring B.V.

11.6.1 Ferring B.V. Company Details

11.6.2 Ferring B.V. Business Overview

11.6.3 Ferring B.V. Acquired Hemophilia Treatment Introduction

11.6.4 Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.6.5 Ferring B.V. Recent Developments

11.7 Sanofi SA

11.7.1 Sanofi SA Company Details

11.7.2 Sanofi SA Business Overview

11.7.3 Sanofi SA Acquired Hemophilia Treatment Introduction

11.7.4 Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2019-2024)

11.7.5 Sanofi SA Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Baxalta

Baxter Healthcare Corporation

List of Tables

Table 1. Global Acquired Hemophilia Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Traditional Therapy

Table 3. Key Players of Advanced Therapy

Table 4. Global Acquired Hemophilia Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 5. Global Acquired Hemophilia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Acquired Hemophilia Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Acquired Hemophilia Treatment Market Share by Region (2019-2024)

Table 8. Global Acquired Hemophilia Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Acquired Hemophilia Treatment Market Share by Region (2025-2030)

Table 10. Acquired Hemophilia Treatment Market Trends

Table 11. Acquired Hemophilia Treatment Market Drivers

Table 12. Acquired Hemophilia Treatment Market Challenges

Table 13. Acquired Hemophilia Treatment Market Restraints

Table 14. Global Acquired Hemophilia Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Acquired Hemophilia Treatment Revenue Share by Players (2019-2024)

Table 16. Global Top Acquired Hemophilia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Hemophilia Treatment as of 2023)

Table 17. Global Acquired Hemophilia Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 18. Global 5 Largest Players Market Share by Acquired Hemophilia Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Acquired Hemophilia Treatment, Headquarters and Area Served

Table 20. Global Key Players of Acquired Hemophilia Treatment, Product and Application

Table 21. Global Key Players of Acquired Hemophilia Treatment, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Acquired Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2019-2024)

Table 25. Global Acquired Hemophilia Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Acquired Hemophilia Treatment Revenue Market Share by Type (2025-2030)

Table 27. Global Acquired Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Acquired Hemophilia Treatment Revenue Share by Application (2019-2024)

Table 29. Global Acquired Hemophilia Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Acquired Hemophilia Treatment Revenue Share by Application (2025-2030)

Table 31. North America Acquired Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 32. North America Acquired Hemophilia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 33. North America Acquired Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 34. North America Acquired Hemophilia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 35. North America Acquired Hemophilia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Acquired Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Acquired Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Acquired Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 39. Europe Acquired Hemophilia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 40. Europe Acquired Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 41. Europe Acquired Hemophilia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 42. Europe Acquired Hemophilia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Europe Acquired Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 44. Europe Acquired Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 45. China Acquired Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 46. China Acquired Hemophilia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 47. China Acquired Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 48. China Acquired Hemophilia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 49. Asia Acquired Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 50. Asia Acquired Hemophilia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 51. Asia Acquired Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 52. Asia Acquired Hemophilia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 53. Asia Acquired Hemophilia Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 54. Asia Acquired Hemophilia Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 55. Asia Acquired Hemophilia Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 61. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 63. Baxalta, Inc. Company Details

Table 64. Baxalta, Inc. Business Overview

Table 65. Baxalta, Inc. Acquired Hemophilia Treatment Product

Table 66. Baxalta, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 67. Baxalta, Inc. Recent Developments

Table 68. Baxter Healthcare Corporation Company Details

Table 69. Baxter Healthcare Corporation Business Overview

Table 70. Baxter Healthcare Corporation Acquired Hemophilia Treatment Product

Table 71. Baxter Healthcare Corporation Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 72. Baxter Healthcare Corporation Recent Developments

Table 73. Bristol-Myers Squibb Company Details

Table 74. Bristol-Myers Squibb Business Overview

Table 75. Bristol-Myers Squibb Acquired Hemophilia Treatment Product

Table 76. Bristol-Myers Squibb Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 77. Bristol-Myers Squibb Recent Developments

Table 78. Genentech, Inc. Company Details

Table 79. Genentech, Inc. Business Overview

Table 80. Genentech, Inc. Acquired Hemophilia Treatment Product

Table 81. Genentech, Inc. Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 82. Genentech, Inc. Recent Developments

Table 83. Novo Nordisk A/S Company Details

Table 84. Novo Nordisk A/S Business Overview

Table 85. Novo Nordisk A/S Acquired Hemophilia Treatment Product

Table 86. Novo Nordisk A/S Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 87. Novo Nordisk A/S Recent Developments

Table 88. Ferring B.V. Company Details

Table 89. Ferring B.V. Business Overview

Table 90. Ferring B.V. Acquired Hemophilia Treatment Product

Table 91. Ferring B.V. Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 92. Ferring B.V. Recent Developments

Table 93. Sanofi SA Company Details

Table 94. Sanofi SA Business Overview

Table 95. Sanofi SA Acquired Hemophilia Treatment Product

Table 96. Sanofi SA Revenue in Acquired Hemophilia Treatment Business (2019-2024) & (US$ Million)

Table 97. Sanofi SA Recent Developments

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Acquired Hemophilia Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Acquired Hemophilia Treatment Market Share by Type: 2023 VS 2030

Figure 3. Traditional Therapy Features

Figure 4. Advanced Therapy Features

Figure 5. Global Acquired Hemophilia Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 6. Global Acquired Hemophilia Treatment Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinic Case Studies

Figure 9. Others Case Studies

Figure 10. Acquired Hemophilia Treatment Report Years Considered

Figure 11. Global Acquired Hemophilia Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Acquired Hemophilia Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Acquired Hemophilia Treatment Market Share by Region: 2023 VS 2030

Figure 14. Global Acquired Hemophilia Treatment Market Share by Players in 2023

Figure 15. Global Top Acquired Hemophilia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired Hemophilia Treatment as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Acquired Hemophilia Treatment Revenue in 2023

Figure 17. North America Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Acquired Hemophilia Treatment Market Share by Type (2019-2030)

Figure 19. North America Acquired Hemophilia Treatment Market Share by Application (2019-2030)

Figure 20. North America Acquired Hemophilia Treatment Market Share by Country (2019-2030)

Figure 21. United States Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Acquired Hemophilia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Acquired Hemophilia Treatment Market Share by Type (2019-2030)

Figure 25. Europe Acquired Hemophilia Treatment Market Share by Application (2019-2030)

Figure 26. Europe Acquired Hemophilia Treatment Market Share by Country (2019-2030)

Figure 27. Germany Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Acquired Hemophilia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Acquired Hemophilia Treatment Market Share by Type (2019-2030)

Figure 35. China Acquired Hemophilia Treatment Market Share by Application (2019-2030)

Figure 36. Asia Acquired Hemophilia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Acquired Hemophilia Treatment Market Share by Type (2019-2030)

Figure 38. Asia Acquired Hemophilia Treatment Market Share by Application (2019-2030)

Figure 39. Asia Acquired Hemophilia Treatment Market Share by Region (2019-2030)

Figure 40. Japan Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Acquired Hemophilia Treatment Market Share by Country (2019-2030)

Figure 50. Brazil Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Acquired Hemophilia Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Baxalta, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 57. Baxter Healthcare Corporation Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 59. Genentech, Inc. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 60. Novo Nordisk A/S Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 61. Ferring B.V. Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 62. Sanofi SA Revenue Growth Rate in Acquired Hemophilia Treatment Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Haemophilia Treatment Market Insights Forecast to 2030

Global Hemophilia Medication Market Research Report 2024

Global Rare Hematology Treatment Market Insights Forecast to 2030

Global Hemophilia A Drug Market Research Report 2024

Global Hemophilia Treatment Medications Market Research Report 2024

Global Medication for Hemophilia Market Research Report 2024

Global Hemophilia Gene Therapy Market Research Report 2025

Human Factor VIII Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemoglobinopathy Treatment Market Insights Forecast to 2030

Acquired hemophilia A Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Haemophilia Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rare Hemophilia Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemophilia monoclonal antibody Market Research Report 2024

Acquired hemophilia A Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Smallpox Treatment Market Insights Forecast to 2030

Global Hemophilia AAV Gene Therapy Market Research Report 2024

Bleeding Disorder Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bleeding Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions